Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders. [electronic resource] by
- Herold, Kevan C
- Gitelman, Stephen E
- Ehlers, Mario R
- Gottlieb, Peter A
- Greenbaum, Carla J
- Hagopian, William
- Boyle, Karen D
- Keyes-Elstein, Lynette
- Aggarwal, Sudeepta
- Phippard, Deborah
- Sayre, Peter H
- McNamara, James
- Bluestone, Jeffrey A
Producer: 20131226
In:
Diabetes vol. 62
Availability: No items available.
|
|
6.
|
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma. [electronic resource] by
- Moore, Paul A
- Zhang, Wenjun
- Rainey, G Jonah
- Burke, Steve
- Li, Hua
- Huang, Ling
- Gorlatov, Sergey
- Veri, Maria Concetta
- Aggarwal, Sudeepta
- Yang, Yinhua
- Shah, Kalpana
- Jin, Linda
- Zhang, Sunan
- He, Leilei
- Zhang, Tengfei
- Ciccarone, Valentina
- Koenig, Scott
- Bonvini, Ezio
- Johnson, Syd
Producer: 20110630
In:
Blood vol. 117
Availability: No items available.
|
|
7.
|
Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial. [electronic resource] by
- Gitelman, Stephen E
- Gottlieb, Peter A
- Rigby, Mark R
- Felner, Eric I
- Willi, Steven M
- Fisher, Lynda K
- Moran, Antoinette
- Gottschalk, Michael
- Moore, Wayne V
- Pinckney, Ashley
- Keyes-Elstein, Lynette
- Aggarwal, Sudeepta
- Phippard, Deborah
- Sayre, Peter H
- Ding, Linna
- Bluestone, Jeffrey A
- Ehlers, Mario R
Producer: 20141124
In:
The lancet. Diabetes & endocrinology vol. 1
Availability: No items available.
|
|
8.
|
Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function. [electronic resource] by
- Long, S Alice
- Rieck, Mary
- Sanda, Srinath
- Bollyky, Jennifer B
- Samuels, Peter L
- Goland, Robin
- Ahmann, Andrew
- Rabinovitch, Alex
- Aggarwal, Sudeepta
- Phippard, Deborah
- Turka, Laurence A
- Ehlers, Mario R
- Bianchine, Peter J
- Boyle, Karen D
- Adah, Steven A
- Bluestone, Jeffrey A
- Buckner, Jane H
- Greenbaum, Carla J
Producer: 20121105
In:
Diabetes vol. 61
Availability: No items available.
|
|
9.
|
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial. [electronic resource] by
- Rigby, Mark R
- DiMeglio, Linda A
- Rendell, Marc S
- Felner, Eric I
- Dostou, Jean M
- Gitelman, Stephen E
- Patel, Chetanbabu M
- Griffin, Kurt J
- Tsalikian, Eva
- Gottlieb, Peter A
- Greenbaum, Carla J
- Sherry, Nicole A
- Moore, Wayne V
- Monzavi, Roshanak
- Willi, Steven M
- Raskin, Philip
- Moran, Antoinette
- Russell, William E
- Pinckney, Ashley
- Keyes-Elstein, Lynette
- Howell, Michael
- Aggarwal, Sudeepta
- Lim, Noha
- Phippard, Deborah
- Nepom, Gerald T
- McNamara, James
- Ehlers, Mario R
Producer: 20141124
In:
The lancet. Diabetes & endocrinology vol. 1
Availability: No items available.
|